T1	Participants 96 118	persons with HIV/AIDS.
T2	Participants 271 365	persons with human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS).
T3	Participants 499 661	11 clinically stable, HIV-infected adults had been treated with highly active, antiretroviral therapy and had HIV plasma RNA levels of less than 10 000 copies/mL.
T4	Participants 1397 1419	persons with HIV/AIDS.
